# Lithium Carbonate

NDC: 72789-174
Generic name: Lithium Carbonate
Labeler / Manufacturer: PD-Rx Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 19820129

FDA application: NDA018558

## Active ingredients

- LITHIUM CARBONATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72789-174"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72789-174
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d20ed2aa-aa56-4709-9e7a-9243c71465c9